Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.
about
Reduced coronary flow reserve in Anderson-Fabry disease measured by transthoracic Doppler echocardiography.Disease-specific cardiovascular positron emission tomography/magnetic resonance imaging: a brief review of the current literatureCardiovascular magnetic resonance: Diagnostic utility and specific considerations in the pediatric population.Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosisTissue characterization of the myocardium: state of the art characterization by magnetic resonance and computed tomography imagingRole of Cardiac MR Imaging in CardiomyopathiesPractical applications of cardiovascular magnetic resonance.The role of imaging in hypertensive heart diseaseReproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance2014 korean guidelines for appropriate utilization of cardiovascular magnetic resonance imaging: a joint report of the korean society of cardiology and the korean society of radiology.The role of magnetic resonance imaging in hypertrophic cardiomyopathy.Cardiovascular magnetic resonance: applications in daily practice.Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy.The emerging clinical role of cardiovascular magnetic resonance imaging.Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosis.Pulmonary arterial hypertension: use of delayed contrast-enhanced cardiovascular magnetic resonance in risk assessment.T1 mapping in cardiac MRI.Myocardial fibrosis as the first sign of cardiac involvement in a male patient with Fabry disease: report of a clinical case and discussion on the utility of the magnetic resonance in Fabry pathology.Stroke and Fabry disease.Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonanceLong-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complicationsNewborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A).Myocardial T1 mapping: techniques and potential applications.The natural history of left ventricular systolic function in Anderson-Fabry disease.Advanced Anderson-Fabry disease presenting with left ventricular apical aneurysm and ventricular tachycardia.Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase ANon-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance.The heart in Anderson-Fabry disease and other lysosomal storage disorders.The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance.Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease.Reduced Right Ventricular Native Myocardial T1 in Anderson-Fabry Disease: Comparison to Pulmonary Hypertension and Healthy Controls.Normal left-atrial structure and function despite concentric left-ventricular remodelling in a cohort of patients with Anderson-Fabry disease.Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.Myocardial lipid content in Fabry disease: a combined 1H-MR spectroscopy and MR imaging study at 3 Tesla.Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy.Myofilament degradation and dysfunction of human cardiomyocytes in Fabry disease.Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry diseaseCardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathyCardiac abnormalities in Anderson-Fabry disease and Fabry's cardiomyopathy.High-Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease.
P2860
Q21245672-A9547354-4305-42EA-BCCC-A687CA0B9C4DQ26739729-FFE8E8E9-E25D-4727-B63E-EA989101A44FQ26767019-CB7FF354-893A-43B3-AE52-98A4BBF0E7CDQ26864740-59B6B16F-B033-4C17-8EBC-BFE555DCC216Q27003231-4975ADCB-D80D-4296-91E9-38C4D4FC7B91Q30279246-7A184254-BC9E-473A-9DAC-8D1B078BF13EQ30381191-709054CA-9104-486A-AF7E-63092BA87B2AQ30410260-656AB768-8530-42E1-BF1E-5DAF5EDD1A72Q30423465-4AD43F6D-314E-4284-AB6C-F85CDD699E42Q30423759-24C7DDBE-B4AC-4907-93CA-0B1FF601989CQ30426380-4E9C9A02-FF78-4E4E-90E7-2D71D9FB2380Q30430740-EFCEB9B6-73BA-4123-B6A3-F4EB87A135FBQ30472637-D5903C4A-35CB-4C81-B36C-704056450A0EQ30475257-E5DC46C9-C88F-484B-81FA-A1D1BEA55DF4Q30476724-723319ED-9F6D-4AD1-8FFA-874C67988CE5Q33773350-2C17B310-AB06-4BCC-8F13-2B974822723BQ33844044-216B29B8-7A02-4C34-83F5-86BA0490619CQ33936963-6C106602-BD4C-4DB0-8E33-4A6E84CF266AQ34061632-E848B849-47B7-4DC9-AB20-924456CD1823Q34515540-6B98959C-985A-4670-B38E-9E296D8EEC49Q34805283-F3558AA9-CEDA-4385-9621-7D4816AAB06DQ34993215-54F79D49-C1FB-483E-82FA-D90C1EFDAAC8Q35174325-FDE8B271-4AB4-4AF9-9400-E7E600DB649DQ35584050-A753A904-394C-4B5F-A07D-7DB639907E61Q35746687-6A70B238-E326-4D1D-8269-D6EF4879C739Q35771337-41814F84-7329-4690-BFB8-7AD4FDDC10C0Q35771353-F8459209-3FA9-4EB5-B256-BBEF44CF0F4EQ35773435-CAE52D4E-26D6-4953-A90D-382E99961BCCQ35845452-911E87F9-2F65-481F-94B1-AA9EB69CA336Q35848678-524B0817-C9F5-4546-9315-0CEEE1547345Q36053157-FECAA897-0CC6-474B-A973-F3FD155979D8Q36061578-F9747982-B07C-43B5-B0A9-2984E803C5C9Q36098649-79CA5FE2-951E-4A69-BEC8-FA559DD0E5DDQ36177437-3D95E7F7-3505-48C1-8374-83457BBF75F2Q36315348-40825B25-A138-4129-AD12-7F18DED3253BQ36691040-2DD8D450-F8B3-4631-B332-DDF808838263Q36758364-60D317DA-3B59-412E-A706-FCDF12E704C5Q36893306-570B1DFD-8210-459B-910D-3D46F0BF8AC1Q37073303-4ED79280-42FA-4901-87A9-B3665911F2ADQ37076050-1BF63A61-92FB-4B82-90ED-E2DB5B79CA0C
P2860
Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Gadolinium enhanced cardiovasc ...... f the myocardial interstitium.
@en
type
label
Gadolinium enhanced cardiovasc ...... f the myocardial interstitium.
@en
prefLabel
Gadolinium enhanced cardiovasc ...... f the myocardial interstitium.
@en
P2093
P1476
Gadolinium enhanced cardiovasc ...... of the myocardial interstitium
@en
P2093
Andrew G Elkington
Atul Mehta
Bhavesh Sachdev
Perry M Elliott
Philip J Leed
William J McKenna
P304
P356
10.1016/J.EHJ.2003.09.017
P577
2003-12-01T00:00:00Z